Paper Demonstrates Tremendous Healthcare Costs Associated with Antibiotic Resistance

Mar 05, 2021 | Christina Baum

A new paper from CDC and the University of Utah published in Clinical Infectious Diseases estimates that the national healthcare costs associated with infections caused by six antibiotic-resistant pathogens cost more than $4.6 billion each year. The paper adds to the body of evidence outlining the tremendous impact of antibiotic resistance, building upon CDC’s 2019 Antibiotic Resistance (AR) Threats Report, which found that, “more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and more than 35,000 people die as a result.”

The six pathogens frequently found in health care settings were listed in the 2019 AR Threats Report as causing nearly 622,400 total infections in 2017:

  • Vancomycin-resistant Enterococcus (VRE)
  • Carbapenem-resistant Acinetobacter species
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Carbapenem-resistant Enterobacterales (CRE)
  • Extended-spectrum cephalosporin resistance in Enterobacterales suggestive of extended-spectrum β-lactamase (ESBL) production
  • Multidrug-resistant Pseudomonas aeruginosa

About Christina Baum

More posts by Christina Baum

Related Posts

NACCHO Cognitive Health Guide FINAL 1
  • Tools & Resources
  • Healthy Aging
  • Healthy Living & Prevention
  • Mobilizing for Action through Planning and Partnerships (MAPP)

New NACCHO Resource: Integrating Brain Health into...

NACCHO, in partnership with the Alzheimer’s Association, is thrilled to launch...

Mar 01, 2024 | Andrea Grenadier

New NACCHO Resource: Integrating Brain Health into...

  • HIV, STI, & Viral Hepatitis
  • HIV, STI, Viral Hepatitis, and Harm Reduction Digest

Digest (February 28, 2024)

HIV, STI, Viral Hepatitis, and Harm Reduction Digest: February 28, 2024

Mar 01, 2024

Digest (February 28, 2024)

EHE Superstars Investing in Community Voices in LA County
  • HIV, STI, & Viral Hepatitis

EHE Superstars: Investing in Community Voices in LA...

This blog continues our new series highlighting collaborative projects between...

Feb 28, 2024 | Anthony Green

EHE Superstars: Investing in Community Voices in LA...

I Stock 1490413668
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Announcing NACCHO’s 2023-2024 Virtual Learning...

NACCHO, with support from the Centers for Disease Control and Prevention’s...

Feb 16, 2024 | Harpur Schwartz, Elana Filipos

Announcing NACCHO’s 2023-2024 Virtual Learning...

Untitled
  • Antibiotic Resistance
  • Community Health
  • Healthcare-Associated Infections
  • ID Featured

NACCHO’s Healthcare Infection Prevention and Control...

The NACCHO Healthcare IPC Summit, supported by CDC Project Firstline, aims to...

Feb 14, 2024 | Jaclyn Abramson

NACCHO’s Healthcare Infection Prevention and Control...

  • HIV, STI, & Viral Hepatitis
  • HIV, STI, Viral Hepatitis, and Harm Reduction Digest

Valentine’s Day Digest (February 14, 2024)

HIV, STI, Viral Hepatitis, and Harm Reduction Digest: February 14, 2024

Feb 14, 2024

Valentine’s Day Digest (February 14, 2024)

I Stock 1131109283
  • Funding Opportunity
  • COVID-19
  • Immunization
  • Partnerships

Request for Proposals: Technical Assistance to Improve...

NACCHO, with support from the Centers for Disease Control and Prevention (CDC),...

Feb 12, 2024 | Tori Decea

Request for Proposals: Technical Assistance to Improve...

I Stock 1791470316
  • Funding Opportunity
  • AmeriCorps
  • Communications & Public Relations
  • Opportunity

Request for Proposals: Communications Consultant for...

NACCHO, in partnership with CDC, is seeking a consultant to create a series of...

Feb 12, 2024 | Andrea Grenadier

Request for Proposals: Communications Consultant for...

  • HIV, STI, & Viral Hepatitis

Balanced Imperfection Harm Reduction Services Survey is...

Balanced Imperfection, with funding from NACCHO, is honored to be able to...

Feb 12, 2024

Balanced Imperfection Harm Reduction Services Survey is...

Back to Top